Inventiva S.A. (IVA) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Inventiva S.A. (IVA).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $3.64

Daily Change: +$0.14 / 3.85%

Daily Range: $3.43 - $3.65

Market Cap: $506,178,400

Daily Volume: 17,614

Performance Metrics

1 Week: 8.82%

1 Month: 7.87%

3 Months: 5.41%

6 Months: 47.81%

1 Year: 60.35%

YTD: 70.09%

Company Details

Employees: 119

Sector: Health technology

Industry: Biotechnology

Country:

Details

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.

Selected stocks

The Marygold Companies, Inc. (MGLD)

Graphjet Technology (GTI)

Greenwave Technology Solutions, Inc. (GWAV)